Table 3 Breast cancer screening rates for the period 2018–2020.

From: Impact of COVID-19 on cancer screening in South Korea

Characteristics

2018 (n = 1754a)

2019 (n = 1795a)

2020 (n = 1800a)

2019 versus 2018

2020 versus 2019

SR, %b

SR, %b

SR, %b

SE

SRR

95% CI

SE

SRR

95% CI

Overall

26.1

26.3

23.0

0.034

1.01

0.94–1.08

0.033

0.88

0.82–0.93

Age group, years

40–49

28.4

28.2

24.1

0.059

0.99

0.88–1.11

0.061

0.85

0.76–0.96

50–59

26.6

28.7

26.1

0.059

1.08

0.96–1.21

0.059

0.91

0.81–1.02

60–69

24.5

24.1

21.7

0.069

0.99

0.86–1.13

0.069

0.90

0.79–1.03

70–74

18.4

20.2

16.4

0.105

1.10

0.89–1.35

0.087

0.81

0.68–0.96

Residential area

Metropolitan

24.4

26.9

19.6

0.050

1.10

1.00–1.22

0.050

0.73

0.66–0.80

Urban

29.4

26.4

27.4

0.051

0.90

0.81–0.99

0.050

1.04

0.94–1.14

Rural

20.2

23.2

19.0

0.100

1.15

0.94–1.40

0.105

0.82

0.67–1.00

Monthly household income ($)

 ≤ 3999

22.4

24.7

22.3

0.057

1.10

0.99–1.23

0.056

0.90

0.81–1.01

4000–6999

27.4

23.6

20.9

0.056

0.86

0.77–0.96

0.058

0.89

0.79–0.99

 ≥ 7000

29.1

31.3

25.8

0.063

1.08

0.95–1.22

0.060

0.82

0.73–0.93

Education status

Middle school or lower

15.2

18.6

18.0

0.079

1.22

1.04–1.42

0.076

0.97

0.84–1.12

High school

27.7

28.0

23.0

0.044

1.01

0.93–1.10

0.044

0.82

0.75–0.90

College or higher

29.6

28.8

27.0

0.068

0.97

0.85–1.11

0.069

0.94

0.82–1.07

Chronic diseasec

No

25.3

27.4

22.0

0.043

1.08

0.99–1.18

0.044

0.80

0.74–0.88

Yes

27.2

24.5

24.2

0.054

0.90

0.81–1.00

0.052

0.99

0.89–1.09

  1. SR screening rate, SRR screening rate ratio, SEstandard error, CI confidence interval.
  2. aThe n value is the number of women eligible for breast cancer screening (aged over 40 years); bSRs were defined as the proportion of screened women within the last 1 year; Weighting values from the Population and Housing Census were applied to calculate the SRs; cChronic disease, women who are diagnosed with any of the following diseases: hypertension, diabetes, tuberculosis, hepatitis B, hepatitis C, liver cirrhosis, chronic gastritis, stomach/duodenal ulcers, polyps, benign breast diseases, uterine myoma, and hyperlipidemia.